Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

FDA approves first 3D-printed drug

A private Pennsylvania company says it has made the first 3D-printed drug to be approved by the US FDA.

The FDA has approved a 3D-printed drug for the first time

Currency issues impacting API manufacturers’ bottom lines

API makers are looking for ways to slash costs and improve efficiencies to counter the impact currency fluctuations and other market challenges, earnings results from Lonza and BASF show.

Success of Allergan integration is the human capital, says Teva

"People are the essence of the company going forward," said Teva, referring to the news that the world's largest generic drug maker will purchase Allergan's generics business for $40.5bn, at its Q2 financial results press conference on Thursday.

News in brief

MannKind ups Afrezza production but Sanofi says sales are modest

MannKind has announced it has opened two extra production lines for inhalable insulin powder Afrezza, its joint venture with Sanofi.

FDA veteran questions science behind antibiotics fast track

As the US regulator awards iclaprim expedited QIDP status, a former FDA antibiotics expert says the scheme boosts antibiotics without enough evidence for efficacy.

Echo's cannabis API delivery formulation could aid low solubility drugs

A drug delivery platform which increased the bioavailability of a cannabis-based drug candidate 30% could be used to boost solubility of other APIs, says Echo Pharmaceuticals.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...